Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Dec 26, 2023
Date Accepted: Mar 14, 2024
Date Submitted to PubMed: Mar 19, 2024

The final, peer-reviewed published version of this preprint can be found here:

Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study

Novella-Navarro M, Iniesta-Chamorro JM, Benavent D, Bachiller-Corral J, Calvo-Aranda E, Borrell-Paños H, Berbel-Arcobé L, Navarro-Compan V, Michelena-Vegas X, Lojo-Oliveira L, Arroyo-Palomo J, García V, Gómez González CM, Monjo-Henry I, Gomez EJ, Balsa A, Plasencia-Rodríguez C

Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study

JMIR Res Protoc 2024;13:e55829

DOI: 10.2196/55829

PMID: 38501508

PMCID: 11074894

Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model.

  • Marta Novella-Navarro; 
  • Jose M. Iniesta-Chamorro; 
  • Diego Benavent; 
  • Javier Bachiller-Corral; 
  • Enrique Calvo-Aranda; 
  • Helena Borrell-Paños; 
  • Laura Berbel-Arcobé; 
  • Victoria Navarro-Compan; 
  • Xabier Michelena-Vegas; 
  • Leticia Lojo-Oliveira; 
  • Jaime Arroyo-Palomo; 
  • Verónica García; 
  • Claudia María Gómez González; 
  • Irene Monjo-Henry; 
  • Enrique J Gomez; 
  • Alejandro Balsa; 
  • Chamaida Plasencia-Rodríguez

ABSTRACT

Background:

Rheumatic and musculoskeletal diseases (RMDs) are chronic diseases that may alternate between asymptomatic periods and flares. These conditions require complex treatments and close monitoring by rheumatologists in order to adjust their effects and improve patient quality of life. Many times, delays in outpatient consultations or patient´s difficulties in keeping appointments make such close follow-up problematic. For this reason, it is very important to have fluid communication channels between patients and health professionals. In this context, the implementation of telemonitoring in the field of rheumatology has great potential, as it can facilitate the close monitoring of patients with RMDs. The use of these tools helps to educate patients about their disease and provide instruction in self-management for certain aspects of their disease. This fact could result in fewer visits to emergency departments and consultations, as well as enable better therapeutic compliance and identification of problems or difficulties that would otherwise go unnoticed

Objective:

The main objective is to evaluate the implementation of a hybrid care model called the mixed attention model (MAM) in clinical practice and to evaluate whether its implementation improves clinical outcomes compared to conventional follow-up.

Methods:

This is a multicenter prospective observational study involving 360 patients with rheumatoid arthritis (RA) and Spondylarthritis (SpA) from five Spanish Hospitals. Patients will be followed-up by the MAM protocol, which is a care model that incorporates the use of digital tool consisting of a mobile application (App) that patients can use at home and that professionals can review asynchronously to detect incidents and to follow their patients' clinical evolution between face-to-face visits. Another group of patients, whose follow-up will be conducted in accordance with a traditional face-to-face care model, will be assessed as the control group. Sociodemographic characteristics, treatments, laboratory parameters, assessment of tender and swollen joints, visual analogue scale for pain and electronic patient reported outcome reports (ePROs) will be collected for all subjects. In the MAM group, these items will be self-assessed both by the mobile App and during face-to-face visits with rheumatologist, who will do the same for patients included in the traditional care model. Patients will be able to report any incidence related to their disease or treatment through the mobile App.

Results:

Recruitment of participants will start in January 2024 and will continue until April 2024. The follow-up period will be extended by 12 months for all patients. Data collection and analysis are scheduled for completion in December 2025.

Conclusions:

The main objective of this protocol article is to provide a detailed description of the development and implementation of a digital solution, in this case a MAM, in the field of RMDs. Overall, this project aims to have both an economic and psychosocial impact on our healthcare system by fostering better and tighter control of RMDs.


 Citation

Please cite as:

Novella-Navarro M, Iniesta-Chamorro JM, Benavent D, Bachiller-Corral J, Calvo-Aranda E, Borrell-Paños H, Berbel-Arcobé L, Navarro-Compan V, Michelena-Vegas X, Lojo-Oliveira L, Arroyo-Palomo J, García V, Gómez González CM, Monjo-Henry I, Gomez EJ, Balsa A, Plasencia-Rodríguez C

Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study

JMIR Res Protoc 2024;13:e55829

DOI: 10.2196/55829

PMID: 38501508

PMCID: 11074894

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.